Episode 436: Hydrochlorothiazide and squamous cell skin cancer – what we know
In episode 436, Mike and James invite Samantha Moe to help us work through the recent evidence suggesting that hydrocholorothiazide is associated with squamous cell skin cancer. We go over all the numbers and talk about how we use cohort data to figure out if an association needs to influence our clinical practice. As always it is tricky.
Show notes
Tools for Practice
Hydrochlorothiazide and Squamous Cell Skin Cancer: Remember when hypertension was easy?
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
